Cargando…
Pharmacotherapy for Fibromyalgia
Fibromyalgia (FM) is a chronic disorder characterized by multifocal pain and other associated somatic symptoms including fatigue, insomnia, cognitive/memory problems, and even psychological distress. It appears that 2–4% of the general population suffers from FM. FM negatively impacts the physical f...
Autores principales: | Smith, Howard S., Bracken, Donna, Smith, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131797/ https://www.ncbi.nlm.nih.gov/pubmed/21772818 http://dx.doi.org/10.3389/fphar.2011.00017 |
Ejemplares similares
-
Duloxetine: A Review of Its Safety and Efficacy in the Management of Fibromyalgia Syndrome
por: Smith, Howard S., et al.
Publicado: (2010) -
Current and Emerging Pharmacotherapy for Fibromyalgia
por: Tzadok, Roie, et al.
Publicado: (2020) -
Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010) -
Sleep Related Epilepsy and Pharmacotherapy: An Insight
por: Kumar, Jaya, et al.
Publicado: (2018) -
Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)